Ortho Caps GmbH
Ortho Caps GmbH
- ISIN: US9901880057
- Land: .
Nachricht vom 27.01.2012 | 16:27
Ortho Caps Files Opposition to Align Technology Patent
Ortho Caps GmbH
27.01.2012 16:27
---------------------------------------------------------------------------
HAMM, Germany, 2012-01-27 16:27 CET (GLOBE NEWSWIRE) --
Ortho Caps GmbH today filed a notice of opposition to Align Technology's
(Nasdaq:ALGN) patent EP 2 263 599. With this filing, Ortho Caps has started the
opposition procedure against the above patent in the European Patent Office
(EPO). If successful, it could lead to the revocation of Align's patent in the
designated member states of the European Patent Organisation.
'This patent describes a CAD/CAM process of fabricating dental models on which
aligners are thermoformed. As an orthodontist, I can assure you that Align has
essentially taken a previously known orthodontic laboratory procedure, together
with a CAD/CAM technique that was already being used in dentistry, to fabricate
orthodontic appliances (aligners), which have been used in orthodontics for
over 50 years. Align patented this as their invention!', said Dr. Wajeeh Khan,
who is an orthodontist, the managing director and founder of Ortho Caps. 'Time
has come to finally end this myth of Align's 'invention'. We have the evidence
and the facts and we are highly confident that Align's patents will be
successfully challenged and overturned.'
Ortho Caps has also filed a 3rd party observation against Align Technology's
pending patent application EP 2 295 004, which was about to be granted by the
European Patent Office. This application relates to a CAD/CAM process for the
production of a set of incremental aligners. This submission has led to an
immediate suspension of the granting process. The application will now undergo
further rounds of examination.
In response to a statement by Roger E. George, Align's vice president, Dr. Khan
said, 'I am not surprised that Align has avoided commenting on the fact that in
2009, after losing a lawsuit against Ormco, Align had to pay $13 million in
cash and $77 million in shares of its common stock to Ormco to settle the case.
In light of that, it is strange to claim the strength and validity of their
patent portfolio.'
Ortho Caps also plans to file oppositions against Align's patents EP 2 263 598
and EP 1 143 872, and invalidate Align's patents EP 1 369 091 and EP 989 828.
Furthermore, Ortho Caps is monitoring and preparing suitable legal means
against the grant of other patent applications assigned to Align Technology at
the European Patent Office.
About Ortho Caps GmbH
Founded in January 2006 by an orthodontist, Dr. Wajeeh Khan, Ortho Caps is a
German dental product company that makes and sells orthodontic aligners. Ortho
Caps aligners are custom made from soft thermoplastics. In the fabrication of
these aligners, no standard thermoplastic material is used. The variety of
materials that are used are chosen according to the patient's treatment needs.
This fully 'customized' TwinAligner(r) system uses two different types of
aligners for day and night use for each treatment step. The use of soft
materials makes the orthodontic treatment more effective and less painful for
patients. Ortho Caps products include orthocaps(r) 'classic', orthocaps(r) 'pro'
and orthocaps(r) 'MxD' systems.
CONTACT: Jocelyne Khan
Ortho Caps GmbH
An der Bewer 8
59069 Hamm
Germany
Tel. +49 (0) 2385 9219-0
info@orthocaps.de
www.orthocaps.com
News Source: NASDAQ OMX
27.01.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Ortho Caps GmbH
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: US9901880057
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Interaktiv
Event im Fokus
Workshops für Anleiheemittenten
Teilnahme für Kapital suchende Unternehmen kostenlos!
07.03. in Düsseldorf, 08.03. in Stuttgart,
19.06. in München, 19.09. in Frankfurt
GBC-Fokusbox
GBC-Vorstandsinterview: BHB Brauholding
Das abgelaufene Geschäftsjahr 2011 ist für die BHB Brauholding Bayern-Mitte AG sehr gut verlaufen, und auch für das laufende Geschäftsjahr stehen die Chancen gut, diesen Erfolg zu wiederholen. Die Aktie verfügte nach 9 Monaten 2011 über ein Eigenkapital pro Aktie in Höhe von 3,43 €. Bei aktuellen Kurs von 2,37 € notiert die Aktie also mit einem Abschlag von rund 30% zum Buchwert.
Im Fokus
BondGuide – der Newsletter für Unternehmensanleihen
14-tägig Analysen, Statistiken, Hintergründe!
Mittelstandsanleihen auf dem Prüfstand: Fundiert, unabhängig, transparent.
Marktanalysen. Vorschauen. Rückblicke. Interviews. Bewertungen. Meinungen. Nachrichten. Köpfe. Übersichten. Tabellen. Kennzahlen. Risikofaktoren. League Tables...
News im Fokus
Fresenius Medical Care AG & Co. KGaA Reports Very Strong Fourth Quarter and Full Year Results; Another Record Year expected for 2012
21. Februar 2012, 08:05
Aktueller Webcast
Der AKTIONÄR News

22. Februar 22:27 US-Börsen im Minus - Dow entfernt sich von 13.000-Punkte-Marke - ...
22. Februar 17:45 Gewinnmitnahmen statt DAX-Rallye: Aareal Bank, Bayer, Commerzbank, ...
22. Februar 16:05 Achtung Solar-Kürzung: Solarworld, Q-Cells, Conergy und Co im Fokus
22. Februar 14:48 Nordex: Anleger aufgepasst!
22. Februar 14:35 Intershop: Enttäuschung trotz Rekordergebnis